Tag: Sanofi

December 21, 2021 Off

Sanofi will acquire Amunix for an upfront payment of approximately $1 billion

By Dino Mustafić

Sanofi will acquire Amunix for an upfront payment of approximately $1 billion and up to $225 million upon achievement of certain future development milestones. The acquisition supports Sanofi’s efforts to accelerate and expand its contributions to innovative medicines for oncology patients, with approximately 20 molecules currently in development. 

April 12, 2021 Off

Sanofi acquires Tidal Therapeutics

By Author

Sanofi has acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a novel mRNA-based approach for in vivo reprogramming…

June 16, 2020 Off

Sanofi invests in vaccine production in France, €490 million over five-years

By Dino Mustafić

Sanofi on Tuesday detailed plans investing in France to increase its vaccines research and production capacities, and contribute in responding to future pandemic risks, aligned with its corporate strategy presented last December, Sanofi will invest €610 million to create a new production site and research center in France with both dedicated to vaccines.